Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Albuquerque, New Mexico 87107


Purpose:

It is our primary hypothesis that pretreatment with arformoterol will provide superior protection against EIB in children with mild-moderate asthma compared to placebo added to the current asthma regimen. Our secondary hypothesis is that nebulized arformoterol has comparable protection against EIB compared to inhaled formoterol by dry powder inhaler.


Study summary:

This study is a randomized, double-blind, double-dummy, crossover clinical trial which will consist of 5 study visits and will last up to 3 weeks. Fifteen children 12-17 years of age with asthma and EIB, regardless of current asthma therapy will be eligible for this trial.


Criteria:

Inclusion Criteria: - Children 12-17 years of age - Physician diagnosed asthma for at least 6 months - Long term controller medication for at least 4 weeks if any being used - Females of child-bearing potential agree to use an acceptable form of birth control for the duration of the study - EIB diagnosed by a positive exercise challenge at screening - Forced expiratory volume in 1 second (FEV1) greater than 70% of predicted at screening visit Exclusion Criteria: - History of cardiac dysfunction - Inability to perform exercise challenge ( i.e., running on treadmill or performing adequate spirometry) - Upper respiratory infection in the last 4 weeks - Severe exacerbation, use of oral steroids, or hospitalization in the last 3 months - Chronic (greater than 2 weeks) use of a Long Acting Beta Agonist (LABA) - Pregnancy or lactation - History of paradoxical bronchospasm with any beta-agonist - Obesity defined as BMI greater than 30 kg/m2


NCT ID:

NCT00662779


Primary Contact:

Principal Investigator
Hengameh Raissy, Pharm.D.
University of New Mexico- Pediatric department


Backup Contact:

N/A


Location Contact:

Albuquerque, New Mexico 87107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 23, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.